These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24767768)

  • 21. Systematic Review of the Human Milk Microbiota.
    Fitzstevens JL; Smith KC; Hagadorn JI; Caimano MJ; Matson AP; Brownell EA
    Nutr Clin Pract; 2017 Jun; 32(3):354-364. PubMed ID: 27679525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis.
    Richter AG; Stockley RA; Harper L; Thickett DR
    Thorax; 2009 Aug; 64(8):692-7. PubMed ID: 19359270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects.
    Liu HX; Tao LL; Zhang J; Zhu YG; Zheng Y; Liu D; Zhou M; Ke H; Shi MM; Qu JM
    Int J Cancer; 2018 Feb; 142(4):769-778. PubMed ID: 29023689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome.
    Engel M; Endesfelder D; Schloter-Hai B; Kublik S; Granitsiotis MS; Boschetto P; Stendardo M; Barta I; Dome B; Deleuze JF; Boland A; Müller-Quernheim J; Prasse A; Welte T; Hohlfeld J; Subramanian D; Parr D; Gut IG; Greulich T; Koczulla AR; Nowinski A; Gorecka D; Singh D; Gupta S; Brightling CE; Hoffmann H; Frankenberger M; Hofer TP; Burggraf D; Heiss-Neumann M; Ziegler-Heitbrock L; Schloter M; Zu Castell W
    PLoS One; 2017; 12(7):e0180859. PubMed ID: 28704452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteriological characteristics of caverns and surrounding pulmonary tissue in patients with pulmonary tuberkulosis].
    Golanov VS; Foĭgel'man EI
    Vrach Delo; 1976 Oct; (10):36-8. PubMed ID: 1022031
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.
    Rindlisbacher B; Schmid C; Geiser T; Bovet C; Funke-Chambour M
    Respir Res; 2018 Jan; 19(1):7. PubMed ID: 29321022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity of the midstream urine microbiome in adults with chronic kidney disease.
    Kramer H; Kuffel G; Thomas-White K; Wolfe AJ; Vellanki K; Leehey DJ; Bansal VK; Brubaker L; Flanigan R; Koval J; Wadhwa A; Zilliox MJ
    Int Urol Nephrol; 2018 Jun; 50(6):1123-1130. PubMed ID: 29651696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
    Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
    Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing microbiotas in the upper aerodigestive and lower respiratory tracts of lambs.
    Glendinning L; Collie D; Wright S; Rutherford KMD; McLachlan G
    Microbiome; 2017 Oct; 5(1):145. PubMed ID: 29078799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroesophageal reflux and idiopathic pulmonary fibrosis: a prospective study.
    Fahim A; Dettmar PW; Morice AH; Hart SP
    Medicina (Kaunas); 2011; 47(4):200-5. PubMed ID: 21829051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis.
    Jia G; Chandriani S; Abbas AR; DePianto DJ; N'Diaye EN; Yaylaoglu MB; Moore HM; Peng I; DeVoss J; Collard HR; Wolters PJ; Egen JG; Arron JR
    Thorax; 2017 Sep; 72(9):780-787. PubMed ID: 28250200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study.
    Morell F; Villar A; Montero MÁ; Muñoz X; Colby TV; Pipvath S; Cruz MJ; Raghu G
    Lancet Respir Med; 2013 Nov; 1(9):685-94. PubMed ID: 24429272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
    Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
    Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The microbiome in respiratory medicine: current challenges and future perspectives.
    Faner R; Sibila O; Agustí A; Bernasconi E; Chalmers JD; Huffnagle GB; Manichanh C; Molyneaux PL; Paredes R; Pérez Brocal V; Ponomarenko J; Sethi S; Dorca J; Monsó E
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.
    Heirali AA; Workentine ML; Acosta N; Poonja A; Storey DG; Somayaji R; Rabin HR; Whelan FJ; Surette MG; Parkins MD
    Microbiome; 2017 May; 5(1):51. PubMed ID: 28476135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.
    Bodlet A; Maury G; Jamart J; Dahlqvist C
    Respir Med; 2013 Nov; 107(11):1781-8. PubMed ID: 24051272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the microbiome-induced glycolytic pathway a harbinger of acute exacerbation of idiopathic pulmonary fibrosis?
    Naikawadi RP
    Thorax; 2020 Mar; 75(3):200-201. PubMed ID: 31974108
    [No Abstract]   [Full Text] [Related]  

  • 40. The Challenging Road of Moving from Association to Causation for Microbiome Research in Idiopathic Pulmonary Fibrosis.
    Segal LN; Molyneaux PL
    Am J Respir Crit Care Med; 2019 May; 199(9):1054-1056. PubMed ID: 30807204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.